CoChat

Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation

Open access
Khera, Nandita, Storer, Barry, Flowers, Mary E.D., Carpenter, Paul A., Inamoto, Yoshihiro, Sandmaier, Brenda M., Martin, Paul J., Lee, Stephanie J. · 2012 · Journal of Clinical Oncology
Cited by 122

The DOI matches its Crossref record.

Abstract

Purpose: Our objective was to describe the incidence of nonmalignant late complications and their association with health and functional status in a recent cohort of hematopoietic cell transplantation (HCT) survivors. Patients and Methods: We determined the incidence of 14 nonmalignant late effects in adults who underwent transplantation from January 2004 through June 2009 at Fred Hutchinson Cancer Research Center who survived at least 1 year after HCT. Data were derived from review of medical records and annual self-reported questionnaires. Results: The 1,087 survivors in the study had a median age at HCT of 53 years (range, 21 to 78 years) and were followed for a median of 37 months (range, 12 to 77 months) after HCT. The prevalence of pre-existing conditions ranged from 0% to 9.8%. The cumulative incidence of any nonmalignant late effect at 5 years after HCT was 44.8% among autologous and 79% among allogeneic recipients; 2.5% of autologous and 25.5% of allogeneic recipients had three or more late effects. Survivors with three or more late effects had lower physical functioning and Karnofsky score, lower likelihood of full-time work or study, and a higher likelihood of having limitations in usual activities. Predictors of at least one late effect were age ≥ 50 years, female sex, and unrelated donor, but not the intensity of the conditioning regimen. Conclusion: The burden of nonmalignant late effects after HCT is high, even with modern treatments and relatively short follow-up. These late effects are associated with poor health and functional status, underscoring the need for close follow-up of this group and additional research to address these complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.4594

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 122

Metadata

Authors
Khera, N., Storer, B., Flowers, M. E. D., Carpenter, P. A., Inamoto, Y., Sandmaier, B. M., Martin, P. J., & Lee, S. J.
Venue
Journal of Clinical Oncology
Published
2012-01-01
Volume
30
Issue
1
Pages
71-77
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2102866713
Cited by
122
References
0
FWCI
5.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation. https://app.cochat.ai/papers/10.1200/jco.2011.38.4594
The paper
Khera, N., Storer, B., Flowers, M. E. D., Carpenter, P. A., Inamoto, Y., Sandmaier, B. M., Martin, P. J., & Lee, S. J. (2012). Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2011.38.4594

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.